Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/12969989http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/12969989http://www.w3.org/2000/01/rdf-schema#comment"

Objective

This study was undertaken to assess the role of vascular smooth muscle cell (VSMC) Ca2+ channels and Ca2+/calmodulin-dependent protein kinase II (CaMKII) in gene regulation after oxidative endothelial injury (OEI).

Methods and results

OEI was produced by infusion of Na fluorescein (NaFluo) photoactivated by UV light immediately before intravenous injection. Posterior cerebral arteries were studied using immunofluorescence imaging, Western blotting, or patch clamping of isolated cells. After infusion of photoactivated NaFluo, but not NaFluo, (1) superoxide dismutase-1 (SOD-1) was upregulated in endothelium, consistent with oxidant stress; (2) the fraction of VSMC nuclei labeled for proliferating cell nuclear antigen (PCNA) increased 7-fold at 6 hours, preceded by a several-fold increase in nuclear phospho-cAMP-response element binding protein, with PCNA upregulation prevented by pretreatment with polyethylene glycol (PEG)-SOD; (3) in VSMCs, phospho-CaMKII increased 20-fold 5 minutes after OEI, with a 2-fold increase in peak Ca2+ channel currents; and (4) changes in cAMP-response element binding protein and PCNA were blocked by systemic administration of lipophilic (nifedipine) or hydrophilic (amlodipine) 1,4-dihydropyridine Ca2+ channel blockers, the calmodulin inhibitor trifluoperazine, or the CaMKII inhibitor KN-93, with none of these agents preventing SOD-1 upregulation in endothelium.

Conclusions

Activation of VSMC Ca2+ channels and CaMKII is a key early signaling event required for upregulation of PCNA gene expression in VSMCs after oxidative injury to endothelium."xsd:string
http://purl.uniprot.org/citations/12969989http://purl.org/dc/terms/identifier"doi:10.1161/01.atv.0000094962.07514.bc"xsd:string
http://purl.uniprot.org/citations/12969989http://purl.uniprot.org/core/author"Zhou H."xsd:string
http://purl.uniprot.org/citations/12969989http://purl.uniprot.org/core/author"Gerzanich V."xsd:string
http://purl.uniprot.org/citations/12969989http://purl.uniprot.org/core/author"Ivanova S."xsd:string
http://purl.uniprot.org/citations/12969989http://purl.uniprot.org/core/author"van der Heijden M.S."xsd:string
http://purl.uniprot.org/citations/12969989http://purl.uniprot.org/core/author"Simard J.M."xsd:string
http://purl.uniprot.org/citations/12969989http://purl.uniprot.org/core/date"2003"xsd:gYear
http://purl.uniprot.org/citations/12969989http://purl.uniprot.org/core/name"Arterioscler Thromb Vasc Biol"xsd:string
http://purl.uniprot.org/citations/12969989http://purl.uniprot.org/core/pages"2048-2054"xsd:string
http://purl.uniprot.org/citations/12969989http://purl.uniprot.org/core/title"Trans-cellular proliferating cell nuclear antigen gene activation in cerebral vascular smooth muscle by endothelial oxidative injury in vivo."xsd:string
http://purl.uniprot.org/citations/12969989http://purl.uniprot.org/core/volume"23"xsd:string
http://purl.uniprot.org/citations/12969989http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/12969989
http://purl.uniprot.org/citations/12969989http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/12969989
http://purl.uniprot.org/uniprot/P04961#attribution-51FE265DB710F36D04D7FA54F8533AE2http://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/12969989
http://purl.uniprot.org/uniprot/#_P04961-mappedCitation-12969989http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/12969989
http://purl.uniprot.org/uniprot/P04961http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/12969989